Nat. Biotechnol. 25, 951β952, 2007; published online 3 September 2007
In the version of this article originally published, in the penultimate paragraph, the name of the Monash University scientist was misspelled; the correct spelling is Colin Pouton. In addition, the statement in paragraph 2 βthe SSCC, which is being supported by the same group that funded ESI, the Agency for Science, Technology and Research (A*STAR)β is incorrect. ESI is not funded by A*STAR. Its major investor is Bio-One Capital, a venture capital fund controlled through the Singapore Government's Economic Development Board. The SSCC is funded by A*STAR.
Additional information
The online version of the original article can be found at 10.1038/nbt0907-951
Rights and permissions
About this article
Cite this article
Baker, M. Erratum: Funding crunch forces stem cell company to abandon therapies. Nat Biotechnol 25, 1488 (2007). https://doi.org/10.1038/nbt1207-1488a
Issue Date:
DOI: https://doi.org/10.1038/nbt1207-1488a
